Table 1. Clinical characteristics of control subjects and ACI patients.
| Control (n=19) | ACI (n=21) | P-value | |
|---|---|---|---|
| Age (years) | 65.6±10.4 | 66.5±9.8 | NS |
| Sex (F/M, %) | 58.2/41.8 | 52.6/47.4 | NS |
| Smoking (%) | 40.2 | 38.8 | NS |
| Hypertension (%) | 46.3 | 79.5 | <0.001 |
| Diabetes mellitus (%) | 32.2 | 28.8 | NS |
| Hypercholesterolemia (%) | 28.8 | 60.3 | <0.001 |
| Peripheral artery disease (%) | 20.1 | 18.6 | NS |
| Prior medication with | |||
| Lipid-lowering drugs | 17.6 | 36.8 | <0.01 |
| Platelet inhibitors | 22 | 46 | <0.001 |
| Atrial fibrillation | 3.5 | 18.2 | <0.001 |
| Platelet count ( × 109/L) | 245±32 | 238±28 | NS |
| Leukocytes ( × 109/L) | 5.6±2.2 | 7.9±2.8 | NS |
| C-reactive protein (mg/mL) | 0.3±0.2 | 15.4±6.6 | <0.001 |
Abbreviation: ACI, actue cerebral infarct.